Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination

INTRODUCTION: Infectious diseases and vaccinations are trigger factors for thrombotic microangiopathy. Consequently, the COVID-19 pandemic could have an effect on disease manifestation or relapse in patients with atypical hemolytic syndrome/complement-mediated thrombotic microangiopathy (aHUS/cTMA)....

Descripción completa

Detalles Bibliográficos
Autores principales: Aigner, Christof, Gaggl, Martina, Schmidt, Sophie, Kain, Renate, Kozakowski, Nicolas, Oszwald, André, Prohászka, Zoltán, Sunder-Plassmann, Raute, Schmidt, Alice, Sunder-Plassmann, Gere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201914/
https://www.ncbi.nlm.nih.gov/pubmed/37360817
http://dx.doi.org/10.1016/j.ekir.2023.05.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201914/
https://www.ncbi.nlm.nih.gov/pubmed/37360817
http://dx.doi.org/10.1016/j.ekir.2023.05.010

Ejemplares similares